TITLE

A new approach to managing intraductal papillary mucinous pancreatic neoplasms

AUTHOR(S)
Ghaneh, Paula; Neoptolemos, John
PUB. DATE
August 2007
SOURCE
Gut;Aug2007, Vol. 56 Issue 8, p1041
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses the developments in the diagnosis and management plan for the treatment of intraductal papillary mucinous pancreatic neoplasms (IPMN's). Diagnostic methods of IPMN's include the identification of clinical symptoms and imaging techniques such as magnetic resonance cholangiopancreatography and tumour marker analysis. The management of the disease include surgery as the main therapeutic option.
ACCESSION #
25972125

 

Related Articles

  • ELEVATED TUMOR MARKER CA 19-9 IN DIFFERENTIAL DIAGNOSIS OF PANCREATIC MASS LESIONS. Ćwik, Grzegorz; Wallner, Grzegorz // Polish Surgery / Chirurgia Polska;2006 Supplement, Vol. 8, p14 

    Background: The aim of the study was to assess the utility of the serum marker, CA 19-9, in the differential diagnosis of pancreatic tumors. Methods: 150 patients with heterogenic pancreatic lesions were diagnosed and treated at the 2nd Department of General Surgery of the University Medical...

  • Utility of Immunohistochemistry in the Pancreatobiliary Tract. Fan Lin; Chen, Zongming Eric; Wang, Hanlin L. // Archives of Pathology & Laboratory Medicine;Jan2015, Vol. 139 Issue 1, p24 

    Context.--Immunohistochemistry has become a useful ancillary study in the identification and classification of pancreatic neoplasms. The diagnostic accuracy has been significantly improved because of the continuous discoveries of tumor-associated biomarkers and the development of effective...

  • The National Awareness and Early Diagnosis Initiative in England: assembling the evidence. Richards, M. A. // British Journal of Cancer;12/3/2009 Supplement 2, Vol. 101, pS1 

    A National Awareness and Early Diagnosis Initiative (NAEDI) has been established in England as part of the Government's strategy to improve cancer outcomes. One of the early priorities for this initiative has been to assemble the diverse evidence linking late diagnosis with poor survival and...

  • The Observatory. Cancer.  // MLO: Medical Laboratory Observer;Dec2015, Vol. 47 Issue 12, p6 

    The article reviews a study by the Mayo Clinic that found that only 19 percent of pancreatic cancer patients in the U.S. receive a widely available, inexpensive blood test at diagnosis that can help predict their likely outcome and guide treatment accordingly.

  • Pancreatic cancer: Practical strategies for early diagnosis and management. Tannery, Krista M.; Rizzolo, Denise // JAAPA: Journal of the American Academy of Physician Assistants (;Oct2013, Vol. 26 Issue 10, p27 

    Pancreatic cancer often is diagnosed too late for effective treatment. Knowing the risk factors, best diagnostic tests, and management options may help clinicians recognize pancreatic adenocarcinoma earlier, improving patient outcomes.

  • Recent advances in pancreatic disease. Al Dulaimi, David // Gastroenterology & Hepatology from Bed to Bench;Winter2015, Vol. 8 Issue 1, p81 

    The article focuses on a study related to diagnosis and management of autoimmune pancreatitis (AIP). Topics discussed include understanding of the epidemiology of pancreatic cancer, performing of surgical treatment with whipple procedure, and prevention and early treatment of infected pancreatic...

  • Branch-duct intraductal papillary mucinous neoplasms of the pancreas: to operate or not to operate? Salvia, Roberto; Crippa, Stefano; Falconi, Massimo; Bassi, Claudia; Guarise, Alessandro; Scarpa, Aldo; Pederzoli, Paolo // Gut;Aug2007, Vol. 56 Issue 8, p1086 

    Background: Branch-duct intraductal papillary mucinous neoplasms (BD-IPMNs) of the pancreas are reported to be less aggressive than the main-duct type. Hence, less aggressive treatment has been proposed for the former. Aim: To evaluate the effectiveness of a follow-up protocol for BD-IPMNs....

  • Solid pseudopapillary neoplasm of the pancreas–proposed algorithms for diagnosis and surgical treatment. Romics, Jr., László; Oláh, Attila; Belágyi, Tibor; Hajdú, Nóra; Gyűrűs, Péter; Ruszinkó, Viktória // Langenbeck's Archives of Surgery;Aug2010, Vol. 395 Issue 6, p747 

    The incidence of solid pseudopapillary neoplasm (SPN) of the pancreas is rising. Although the evidence for proper management is accumulating, we still lack diagnostic and therapeutic guidelines. In this paper, therefore, we propose an algorithm for diagnosis and treatment of this rare type of...

  • SSAT/AGA/ASGE State of the Art Conference on Cystic Neoplasms of the Pancreas. Simeone, Diane M. // Journal of Gastrointestinal Surgery;Aug2008, Vol. 12 Issue 8, p1475 

    Cystic tumors of the pancreas are an increasingly recognized clinical entity, and the management of these lesions continues to evolve. The Society for Surgery of the Alimentary Tract, American Gastroenterological Association, and American Society for Gastrointestinal Endoscopy recently held a...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics